NCT00898508 2025-06-25
Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
City of Hope Medical Center
Completed
Clinical Trials
8 trialsNCT00436566 2022-08-05
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Mayo Clinic
Phase 2 Completed
NCT01105312 2017-06-27
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 1/2 Completed
NCT01132560 2017-05-17
Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ
Eastern Cooperative Oncology Group
Completed
NCT00896857 2017-03-15
Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer
Wake Forest University Health Sciences
Completed
NCT02450357 2015-12-30
The Detection of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
Fuda Cancer Hospital, Guangzhou
Completed
NCT01138345 2014-02-27
Biomarkers in Blood Samples From Older Breast Cancer Survivors
UNC Lineberger Comprehensive Cancer Center
Completed
NCT00897091 2013-05-30
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil
SWOG Cancer Research Network
Completed